COLUMBUS, OH – Ohio Attorney General Dave Yost announced on Monday, June 16, 2025, that 49 states, the District of Columbia, and five U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma and the Sackler family, its owners. This landmark deal, pending approval from a federal bankruptcy judge, includes up to $198 million for Ohio to support addiction recovery efforts.
The settlement addresses decades of aggressive opioid marketing by Purdue under the Sacklers, a key factor in America’s worst drug crisis. It ends the family’s control of the company and prohibits them from selling opioids in the U.S. Nationwide, funds will be distributed over 15 years to enhance treatment, prevention, and recovery services.
This settlement marks the latest in a string of settlements that Attorney General Yost and his staff have brokered to help fund opioid recovery in Ohio. Their previous work includes:
- An $808 million settlement with opioid distributors Cardinal Health, McKesson and AmerisourceBergen.
- A $185 million settlement with Johnson & Johnson and Janssen Pharmaceuticals Inc.
- A $24.7 million settlement with McKinsey & Co.
- A $114 million settlement with Walmart
- A $679 million settlement with drug makers Teva and Allergan and pharmacies CVS and Walgreens
In Ohio, the allocation follows the OneOhio plan: 55% to the OneOhio Recovery Foundation, 30% to local governments, and 15% to the state, pending bankruptcy court approval, with a hearing scheduled soon. “This is another major step toward accountability and recovery,” Yost said. “The money won’t undo the damage, but it will help communities address the harm.”
This settlement builds on Yost’s prior efforts, including an $808 million deal with opioid distributors Cardinal Health, McKesson, and AmerisourceBergen; $185 million from Johnson & Johnson and Janssen; $24.7 million from McKinsey & Co.; $114 million from Walmart; and $679 million from Teva, Allergan, CVS, and Walgreens. Local governments nationwide are now invited to join the agreement.
